Cyberonics, Inc. (Cyberonics) is a medical device company. The Company is engaged in the design, development, sales and marketing of implantable medical devices that provide a neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy), for the treatment of refractory epilepsy and treatment-resistant depression (TRD) and other device solutions for the management of epilepsy.VNS Therapy System includes an implantable pulse generator to provide stimulation to the vagus nerve; a lead that connects the generator to the vagus nerve; equipment to assist with implantation surgery; equipment to assist with setting the stimulation parameters for each patient; instruction manuals, and magnets to suspend or induce stimulation manually. The VNS Therapy pulse generator and lead are surgically implanted into patients generally during an outpatient procedure. The VNS Therapy System consists of a pulse generator, a bipolar lead, a programming wand and software and a tunneling tool.
|Headquarters||The Cyberonics Building|
100 Cyberonics Boulevard
HOUSTON, TX, United States 77058
|President, Chief Executive Officer, Director||Daniel Moore|
|Chief Financial Officer, Senior Vice President - Finance||Gregory Browne|
|Senior Vice President, Chief Administrative Officer, Secretary||David Wise|
|Senior Vice President - Research & Development||Milton Morris|
|Chief Compliance Officer, Vice President, General Counsel, Assistant Secretary||Darren Alch|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||27.6M||Book Value||$8.29|
|Annual Dividend Rate||$0.00||Price/Sales (TTM)||5.6|
|Ex-Div Date||1/1/01||P/Cash Flow (TTM)||27.7x|
|Pay Date||1/1/01||Operating Margin||29.21%|
*GAAP = prior to non-GAAP analyst adjusted earnings.